NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/27/2024
Back to search
Official data from USPTO
NUCALA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
62
Latest update
08/27/2024
Trademark type
Word
Nice classes
5
Filing date
07/14/2011
Registration date
04/07/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
08/27/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Stevenage, GB
Examiner
ZAK, HENRY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glaxo Group Limited
Glaxo Group Limited
Glaxo Group Limited
Representatives
Christopher M. Hanes GLAXOSMITHKLINE
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders ; Vaccines
Publications
History of USPTO decisions and trademark events.
62 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/27/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/13/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/08/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/15/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/15/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2021
E815
TEAS SECTION 8 & 15 RECEIVED
02/08/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/20/2015
PUBO
PUBLISHED FOR OPPOSITION
01/20/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/31/2014
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/17/2014
PCGR
PETITION TO DIRECTOR GRANTED
12/16/2014
APET
ASSIGNED TO PETITION STAFF
12/16/2014
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
12/04/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2014
EX5G
SOU EXTENSION 5 GRANTED
06/20/2014
EXT5
SOU EXTENSION 5 FILED
06/19/2014
EEXT
SOU TEAS EXTENSION RECEIVED
06/19/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/14/2014
EX4G
SOU EXTENSION 4 GRANTED
01/13/2014
EXT4
SOU EXTENSION 4 FILED
01/03/2014
EEXT
SOU TEAS EXTENSION RECEIVED
01/03/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/17/2013
EX3G
SOU EXTENSION 3 GRANTED
08/16/2013
EXT3
SOU EXTENSION 3 FILED
08/07/2013
EEXT
SOU TEAS EXTENSION RECEIVED
08/07/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/25/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/15/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/15/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/13/2013
EX2G
SOU EXTENSION 2 GRANTED
02/12/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/12/2013
EXT2
SOU EXTENSION 2 FILED
01/30/2013
EEXT
SOU TEAS EXTENSION RECEIVED
01/30/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/04/2012
EX1G
SOU EXTENSION 1 GRANTED
08/02/2012
EXT1
SOU EXTENSION 1 FILED
08/02/2012
EEXT
SOU TEAS EXTENSION RECEIVED
08/02/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/14/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2011
PUBO
PUBLISHED FOR OPPOSITION
12/20/2011
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2011
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/14/2011
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/11/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2011
DOCK
ASSIGNED TO EXAMINER
11/03/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2011
NWAP
NEW APPLICATION ENTERED
07/18/2011
Continuous trademark protection
Get notified about every new filing that threatens NUCALA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.